(Q43621469)

25 November 2017

title

Risperidone versus haloperidol in long-term hospitalized chronic patients in a double blind randomized trial: a post hoc analysis (English)

1 reference

25 November 2017

1 reference

1 reference

1 reference

J Rabinowitz

1

1 reference

25 November 2017

M Davidson

series ordinal

2

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

25 November 2017

published in

Schizophrenia Research

1 reference

25 November 2017

volume

50

1 reference

25 November 2017

issue

1-2

1 reference

25 November 2017

page(s)

89-93

1 reference

Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900163-8

7 January 2021

Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900163-8

7 January 2021

Publication bias and the integrity of psychiatry research.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900163-8

7 January 2021

The positive-negative distinction in drug-free schizophrenic patients. Stability, response to neuroleptics, and prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900163-8

7 January 2021

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900163-8

7 January 2021

Risperidone in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900163-8

7 January 2021

Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900163-8

7 January 2021

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900163-8

7 January 2021

Bias in analytic research

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900163-8

7 January 2021

A controlled dose comparison of haloperidol in newly admitted schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900163-8

7 January 2021

10.1016/S0920-9964(00)00163-8

Identifiers

DOI

1 reference

25 November 2017

1 reference